CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
No Impact of Insulin Resistance on Antiviral Efficacy of Telaprevir-based regimen in HCV Genotype 1 Treatment-Naive Patients: Subanalysis of C208 Study
DOI 10.1055/s-0030-1269677
Bibliografische Angaben
Nachweis in CareLit
Autor:innenT Goeser, P Buggisch, S Mauss, J Rasenack, H Wedemeyer, S Decker-Burgard, L Serfaty
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe01/2011
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Insulin resistance is a predictor of poor response with peginterferon and ribavirin (PEG-IFN/RBV; PR) in chronic hepatitis C (CHC) genotype 1 (G1) patients(pts).Objective of this exploratory analysis was to assess the impact of metabolic factors and insulin resistance by HOMA index on virologic response in European CHC G1 patients treated with telaprevir (T). Methods: 161 G1 pts, randomized into 4 arms, received 12…
Zitieren
Zitierempfehlung
T Goeser, P Buggisch, S Mauss, J Rasenack, H Wedemeyer, S Decker-Burgard, L Serfaty (2011) No Impact of Insulin Resistance on Antiviral Efficacy of Telaprevir-based regimen in HCV Genotype 1 Treatment-Naive Patients: Subanalysis of C208 Study. Zeitschrift für Gastroenterologie (01). https://doi.org/10.1055/s-0030-1269677
Mit CareLit weiterarbeiten